Clinical Study
Intravitreal Dexamethasone in the Management of Delayed-Onset Bleb-Associated Endophthalmitis
| | IVD | No IVD | value | | 71/84 (84%) | 13/84 (16%) |
| VA, pre-endophthalmitis | | | | Mean | 20/90 | 20/70 | 0.57 | Range | 20/20-LP | 20/25–20/400 | | VA, presentation | | | | Mean | 0.9/200 | 1.7/200 | 0.23 | Range | 20/40-NLP | 20/80-LP | | VA, 1 month | | | | Mean | 5/200 | 1.8/200 | 0.14 | Range | 20/25-NLP | 20/25-NLP | | ≥3 lines Improvement | 44 (67%) | 3 (25%) | 0.01 | logMARΔ | 0.85 | 1.56 | 0.02 | VA, 3 months | | | | Mean | 7/200 | 3/200 | 0.36 | Range | 20/25-NLP | 20/25-LP | | ≥3 lines Improvement | 36 (64%) | 3 (33%) | 0.14 | logMARΔ | 0.74 | 1.33 | 0.14 |
|
|